human studies bpc 157 FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list BPC-157 Explained: Benefits, Safety &

Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles

Selank injections should be administered once per day at a dose from 150mcg to 300mcg [17]

We are transparent about the current state of the evidence and discuss it with every patient during consultation.

Similarly, pregnant or breastfeeding individuals should avoid use given unknown effects on fetal development